# Study on PK of Hydronidone in Patients and Special Population

> **NCT04123769** · PHASE1 · COMPLETED · sponsor: **Beijing Continent Pharmaceutical Co, Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Hepatitis b & Liver Dysfunction

## Interventions

- **DRUG:** Hydronidone

## Key facts

- **NCT ID:** NCT04123769
- **Lead sponsor:** Beijing Continent Pharmaceutical Co, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-03
- **Primary completion:** 2020-10-09
- **Final completion:** 2021-01-30
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04123769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04123769, "Study on PK of Hydronidone in Patients and Special Population". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04123769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*